Subscribe

Renegade
Neurologist
RSS Feed

Search

Wellness Health
Visit Our Sponsor »

Archive for December, 2007

Sunlight Helps Put Lung Cancer in the Shade

The more rays people caught, the less prone they were to get the disease, study found

From HealthDay

Something as common and available as sunlight may help prevent some lung cancers, researchers say.

A new study finds that lower levels of the sun’s ultraviolet B (UVB) rays are associated with a higher incidence of lung cancer across 111 countries.

Still, that doesn’t mean that spending more time in the sun will ever offset the risks that come with smoking, according to the study, which is published in the January issue of the Journal of Epidemiology and Community Health.

It’s also not an excuse to trade skin cancer for lung cancer.

“The problem is that people might over-interpret this and stay in the sun for hours,” said Cedric Garland, study senior author, professor of family and preventive medicine at the University of California, San Diego (UCSD), and participating member at the Moores UCSD Cancer Center in La Jolla.

Too little sun isn’t great either, however, since sunlight helps the skin manufacture healthy vitamin D. “It would be false prudence to stay out of the sun to prevent skin cancer and not get enough vitamin D,” Garland said.

Other experts, however, feel the focus should stay on cigarette smoking as the number one cause of lung cancer.

“When you have such a strong factor as tobacco, it really weighs out all these other small influences,” said Dr. Jay Brooks, chairman of hematology/oncology at the Ochsner Health System in Baton Rouge, La. “It’s a very interesting observation, but the main message is tobacco is such a strong influence in the development of lung cancer that we should concentrate on that.”

More than one million people die of lung cancer worldwide each year. Cigarette smoking causes about 85 percent of lung cancers. The remaining cases are caused by exposure to secondhand smoke and a variety of other (some unknown) factors.

Sunshine is a significant source of vitamin D, as the sun’s UV rays trigger synthesis of vitamin D in the skin.

Previous research, much of it by the same group, has found a strong association between breast cancer, colon cancer and other internal-organ cancers and living in latitudes with less sunlight. For example, one paper observed double the death rate from colon cancer above the U.S. Mason-Dixon line as below, leading the researchers to focus on lack of sunlight as the culprit.

It wasn’t a new idea. “There were people in epidemiology dating back to Hippocrates who thought it was a good idea to live on the south side of a hill,” Garland said.

Another study linked lower levels of a vitamin D metabolite in the blood with a higher level of colon cancer.

For this study, Garland and his colleagues looked at the association between latitude and exposure to UVB light and rates of lung cancer in 111 countries. Data came from an extensive United Nations database.

Although smoking showed the strongest association with lung cancer, exposure to UVB light also had an impact.

UVB light is greatest closer to the equator. This study showed that lung cancer rates were highest in regions farthest away from the equator and lowest in those regions nearest to it.

Higher cloud cover and aerosol use (both of which absorb UVB rays) were linked with higher rates of lung cancer.

For men, smoking was associated with higher rates of lung cancer, while greater exposure to sunlight was associated with lower rates.

For women, cigarette smoking, along with total cloud cover and aerosol levels, were associated with higher rates of lung cancer, while sunlight was again associated with lower rates.

Previous research has indicated that vitamin D may be able to stop the growth of malignant tumors.

“Everyone should be taking vitamin D, and, at all latitudes, there’s plenty of potential to make vitamin D,” Garland said. “Even in Helsinki, people can take advantage of the sun in summer months.”

And vitamin D produced in the summer will carry over into the winter. Even so, unless you know what your vitamin D levels are, it might be wise to take a supplement, Garland advised.

Share this Article:

Mailing List:


Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients

First, prescribed to protect the heart, can lead to halting of cancer therapy, report saysFrom HealthDay

Men undergoing hormone therapy for prostate cancer who take baby aspirin to protect their heart run a significantly higher risk of dying, new research suggests.

Apparently, baby aspirin interacts with the hormone therapy to elevate liver-function test levels. The end result is the man must stop potentially lifesaving hormone therapy.

The findings are contained in a letter published in the Dec. 27 issue of the New England Journal of Medicine.

Hormonal therapy, which involves reducing levels of male hormones called androgens, is a common treatment for prostate cancer, but it can raise the risk of a heart attack. So men who are older or have known coronary risk factors such as diabetes or smoking usually take baby aspirin while undergoing hormone therapy because aspirin helps prevent blood clots.

“Aspirin is being prescribed more widely for these men so we looked to see if there was any effect of aspirin on prostate cancer outcomes,” said lead researcher Dr. Anthony V. D’Amico, chief of the division of genitourinary radiation oncology at Brigham & Women’s Hospital and the Dana-Farber Cancer Institute, both in Boston.

The authors analyzed data on 206 men with localized prostate cancers who were already enrolled in a trial to compare radiation therapy alone with radiation therapy plus hormone therapy. The hormone therapy included six months of the anti-androgen flutamide.

Flutamide had a tendency to elevate results of liver-function tests. Although these elevations were benign, they meant hormonal therapy had to be stopped, at least temporarily, D’Amico explained.

Men who didn’t complete six months of hormone therapy were 3.5 times more likely to die compared to men who got the full course of hormone therapy.

“It was sort of a paradoxical finding,” D’Amico said. “Men who were taking aspirin were more likely to die of prostate cancer than those who were not, which didn’t make sense at first.”

But when the researchers delved deeper, they realized that the men who were taking aspirin were more likely to have to stop hormone therapy.

“Liver function is something you monitor” when undergoing hormone therapy, D’Amico explained. “When the tests elevate, you take the patient off of hormone therapy till the tests normalize, then you restart the therapy.”

An explanation for this interaction comes from previous animal studies, D’Amico said. For rabbits that take aspirin while undergoing hormone therapy, that aspirin is magnified 100-fold in terms of how much gets into the blood. “That makes it a toxic dose of aspirin,” he explained.

Although such a study can’t establish a cause-and-effect association, it does appear likely, D’Amico said.

“If a man is taking baby aspirin just to prevent heart disease, we would ask the oncologist to ask the primary-care physician if he could come off the baby aspirin for the months while he’s getting cancer therapy. If the aspirin is just for prevention, this is probably the simplest thing to do,” he said. “But if the patient is on aspirin because he absolutely needs it, then they’d have to treat the prostate cancer without hormone therapy. It really comes down to a trade-off: How much do they need the aspirin versus how much do they need hormonal therapy, and there are alternative treatments for prostate cancer.”

Share this Article:

Mailing List:


Bengay Death Highlights OTC Dangers

Just because it’s nonprescription doesn’t mean it’s harmless, experts caution in wake of teen track star’s overdose from sports cream

From HealthDay

The bizarre death of a New York City high school track star from a muscle pain cream overdose is raising a red flag once again on the hazards of overusing common over-the-counter medications, experts say.

The New York City medical examiner’s office ruled last week that 17-year-old cross-country runner Arielle Newman died from an accidental overdose of methyl salicylate, the wintergreen-scented ingredient found in popular sports balms.

To help ease exercise-related discomfort, the Staten Island teenager reportedly had been putting Bengay on her legs between running meets, while also using adhesive pads with methyl salicylate, an aspirin-like anti-inflammatory, and a third product, according to the Associated Press.

“There were multiple products, used to great excess,” Ellen Borakove, a spokeswoman for the NYC medical examiner’s office, told the AP. All of the products can be found as nonprescription items on drug store shelves.

But over-the-counter almost never means “harmless,” experts warned.

Methyl salicylate, or salicylic acid, is the active ingredient in creams such as Bengay, Icy Hot and Tiger Balm, as well as aspirin, and “is potentially harmful if it is overused,” said Dr. Gerard Varlotta, the director of sport rehabilitation at Rusk Institute of Rehabilitation Medicine in New York City.

An anti-clotting agent, salicyclic acid at very high doses “can cause internal bleeding, it can cause arrhythmias of the heart, it can cause problems in the liver — there are any number of ways it can get to you,” Varlotta added.

However, long-familiar brands like Bengay (which first debuted in U.S. drug stores more than 100 years ago) don’t set off alarm bells in most Americans’ minds, so the temptation to overuse them is there, Varlotta said.

And while most people would definitely think twice about swallowing a fistful of aspirin or other OTC pills, people forget that creams carry dangers, too.

“Remember, there are a whole variety of [medicinal] products that are specifically formulated to be absorbed through the skin,” Varlotta said.

As with any drug, moderation is key, another expert added.

“You have to follow the directions, because the poison is in the dose,” advised Elena Juris, an education outreach specialist at the American Association of Poison Control Centers in Washington, D.C. And that maxim applies to creams just as much as it does to pills, she said.

Her groups’ statistics for 2005 show that 14 Americans died from skin exposures to some kind of toxic substance, although a breakdown on exactly which substances caused those deaths has not yet been compiled, Juris said.

However, she noted that, “the seventh most common substances involved in human exposures from poisoning are, in fact, topical preparations. In 2005, poison control centers reported 109,831 exposures related to topical substances.”

Newman’s Bengay-linked death was an extremely rare occurrence, however, and Johnson & Johnson, which makes the cream, told AP that their product “is safe and effective when used as directed to provide relief from minor arthritis pain, sore, aching and strained muscles and backaches.”

Similar to advice given for prescription drugs, it’s crucial that consumers carefully read label instructions and warnings for all OTC products. Varlotta believes that the cautions could be better highlighted, however.

“If you look at all of these [OTC] products, you cannot tell anything from the outside of the box,” he said. In the case of the Bengay that Newman used, “there’s nothing in big letters that says that it contains aspirin,” Varlotta said. “It’s in the fine print.”

Many consumers also fail to realize that the same drug can pop up in multiple, and very different, OTC products.

“Cough and cold preparations are a common mistake,” Juris said. “You might be taking a cold preparation that includes acetaminophen, and you also take acetaminophen [pills] for headache. So, you are overdosing it right there. So, it’s not just looking at the label for directions, it’s also making sure that you are not combining products and increasing the recommended dosage.”

Other OTC products on Varlotta’s radar include the painkillers Advil or Motrin (two or three OTC pills equal the dose in one prescription-strength pill, he noted), a host of poorly regulated herbals and dietary supplements, and Voltaren, an anti-inflammatory muscle cream that many of his patients bring back with them from Europe.

Voltaren isn’t approved for OTC sale in the United States, Varlotta said, but it can cause real problems for Americans who bring it home.

“People come back, and they are given a prescription by their doctor for another anti-inflammatory, so that means they’re now using the cream plus the anti-inflammatory, and they end up getting gastrointestinal problems, bleeding,” he said. “And then I tell them: ‘Let me see the cream.’ And sure enough, it’s Voltaren or some other cream they’ve brought back.”

The bottom line, according to the experts, is that every drug — even a nonprescription cream — comes with some level of risk.

“Just because it’s OTC doesn’t mean that it’s entirely safe and that it can be used against the directions that are being set out by the makers,” Varlotta said. “People should know what they are taking, both orally and on their skin.”

Share this Article:

Mailing List:


Everyday Choices Can Influence Cancer Risk

More salads, exercise, can keep lung tumors at bay, one study found

From HealthDay

While genes and environment can affect your risk for cancer, so can everyday lifestyle choices on things such as diet, exercise and smoking, new research shows.

The findings were to be presented Friday in Philadelphia at an American Association for Cancer Research conference on cancer prevention.

One study found that people who quit smoking can further reduce their risk of lung cancer by eating plenty of vegetables (four or more servings of salad a week or equivalent). The researchers at the University of Texas M.D. Anderson Cancer Center also found that former smokers who get exercise through gardening are 45 percent less likely to get lung cancer than former smokers who don’t garden.

Current smokers who ate three servings or less of salad a week were two times more likely to develop lung cancer than current smokers who ate four or more salads a week. Current smokers who gardened were 33 percent less likely to get lung cancer than current smokers who didn’t garden, the Texas team found.

“Although this is a very preliminary analysis, it give us some important clues about how everyone — smokers and non-smokers alike — might be able to reduce their risk of developing lung cancer,” Michele Forman, a professor of epidemiology at the University of Texas, said in a prepared statement.

“If you are worried about lung cancer risk, this study shows that you may benefit from eating a healthy diet and being physically active,” she said.

A second study suggests that males may be more prone to developing cancer than females because of gender differences in antioxidant levels and the ability to repair DNA damage.

The Ohio State University study found that the same degree of damaging ultraviolet (UV) light caused more damage to the skin of male mice than to that of female mice. As a result, the male mice developed more squamous cell skin cancers, and these tumors grew more quickly and aggressively than the same type of tumors on the skin of female mice.

The findings may help explain why men develop three times as many squamous cell skin cancers than women and why men are more prone to developing cancer in general, the researchers said.

“Men get more skin cancer than women, and it has classically been thought that the reason for this is lifestyle — men spend more time outside and are less likely to use sun protection,” Kathleen Tober, a research scientist in OSU’s pathology department, said in a prepared statement. “Our data suggests that while that may be a factor, an even more critical reason for this difference is that female skin may be better able to combat the damaging effects of UV exposure.”

“Based on our data, it would be a reasonable hypothesis that one of the underlying mechanisms for this is that men might have less overall antioxidant levels and diminished DNA repair capacity,” Tober said.

A third study found that black Americans may have a more difficult time giving up smoking, because they have much lower levels of an enzyme (glucuronide) that metabolizes nicotine and nicotine byproducts than whites. This means that blacks may experience higher nicotine levels when smoking, which makes it more difficult for them to kick the habit.

“Smokers adjust their level of smoking to maintain blood levels of nicotine, which are determined in part by rates of nicotine metabolism, and, while we can’t say from this study that differences in metabolism definitively account for lower quit rates (among blacks), it could very well have an impact,” Jeannette Zinggeler Berg, an M.D./Ph.D. student in biochemistry, molecular biology, and biophysics at the University of Minnesota, said in a prepared statement.

Share this Article:

Mailing List:


Report: Readiness for flu outbreaks spotty

From USATODAY.com

Thirteen states don’t have adequate plans to distribute vaccines and antidotes in the event of a flu pandemic or a bioterrorism attack, according to a health preparedness report out Tuesday.

The Trust for America’s Health, a non-partisan research organization, found that states have made significant progress in preparing for major health emergencies since 9/11 and the anthrax attacks of 2001. But large gaps in readiness still exist, the report said.

“Emergency health preparedness is on the national radar, but until all states are equally well prepared, our country is not as safe as it can or should be,” said Jeff Levi, director of the Trust.

The Trust used 10 indicators to rate a state’s preparedness. They ranged from the state’s ability to distribute drugs from the national stockpile to whether the state uses a disease surveillance system that’s compatible with the government system at the federal Centers for Disease Control and Prevention (CDC) in Atlanta.

Seven states got a perfect score: 10 out of 10. Six were at the bottom of the spectrum, scoring six out of 10.

FIND MORE STORIES IN:Centers for Disease Control and Prevention | Emergency | Flu | Irwin Redlener

Among the findings outlined in the report:

Flu vaccination rates decreased among the elderly in 11 states during the past year.

Seven states and Washington, D.C., lack sufficient capacity to test for biological threats.

21 states don’t give liability protection to health care workers who volunteer during emergencies.

Six states cut their public health budgets between fiscal 2005 and fiscal 2006.

Seven states haven’t joined a federal program to buy lower-cost antiviral drugs.

Richard Besser, director of Terrorism Preparedness and Emergency Response at the CDC, said states have made tremendous strides in the past five years. In the 13 states that don’t have plans to distribute drugs from the stockpile, various creative approaches are being tested, he said.

Among them: Giving employers caches of drugs to distribute during a crisis and having postal workers deliver drugs house to house.

Long-term, Besser says he’s worried about how to keep emergency preparedness fine-tuned in the absence of an attack or a major outbreak.

“A well-working public health system is invisible to the community, but it’s absolutely essential,” he said.

Irwin Redlener, associate dean of Public Health Advocacy and Disaster Preparedness at Columbia University’s Mailman School of Public Health, said he’s particularly concerned about hospitals and their ability to deal with sudden surges of large patients during a disaster.

“Hospitals have become way stations for the millions of Americans that don’t have health care, so emergency rooms already are overcrowded,” Redlener said.

“I shudder to think what would happen in the event of a large-scale disaster.”

Share this Article:

Mailing List: